Sotagliflozin Treatment Improves Survival and Shorten Hospital Stays in Type 2 Diabetes Patients, Study Reveals

A study reveals that treatment with sotagliflozin in hospitalized patients with type 2 diabetes or T2D leads to an increase in the number of days alive and out of the hospital or DAOH, a metric that may provide an additional patient-centered outcome to capture the totality of disease burden.

Sotagliflozin Treatment Improves Survival and Shorten Hospital Stays in Type 2 Diabetes Patients, Study Reveals
Photo: Sotagliflozin Treatment Improves Survival | InStyleHealth


There was a total of 1,222 patients with T2D and reduced or preserved ejection fraction who were recently hospitalized for worsening heart failure at 306 sites in 32 countries were randomized to receive 200mg of sotagliflozin once a day, with a possible dose increase to 400mg or matching placebo. DAOH and its converse (days dead and in the hospital) were analyzed using pre-specified Poisson regression models.

Proportion of patients hospitalized at least once was comparable between sotagliflozin and placebo groups, 38.5% vs 41.4%, however, fewer patients on sotagliflozin were hospitalized more than once, 16.3% vs 22.1% or had died, 64 vs 76.

Specifically, the rate of DAOH was 3% higher in the sotagliflozin than in the placebo group. Difference was driven by a reduction in the rate of days dead rather than by the reduction in the rate of days hospitalized for any causes.

Moreover, patients on sotagliflozin medication were alive and out of the hospital for 2.9 more days than those on placebo, 91.8 vs 88.9 days, for every 100 days of follow-up. With the difference showed a 2.6-day difference in days dead, 6.3 vs 8.9 days, and a 0.3-day difference in days hospitalized.

Researchers said that further studies are needed to quantify the consequences of increasing DAOH (days alive and out of hospital) in terms of health economics and patient quality of life.

 

Source: Ann Intern Med 2021;doi:10.7326/M21-0651

If you have any suggestions, please let us know.

Post a Comment (0)
Previous Post Next Post